Komiya, Takefumi, Medical Oncology, Parkview Cancer Institute, 11050 Parkview Circle, Fort Wayne, IN 46845, United States
-
Vol. 13, No. 1, Feb 2022 - Review
Advances in the Treatment of Mucoepidermoid Carcinoma
Abstract HTML PDF
MOST READ |
(For the last 6-month published articles)
INDEXED IN |
QUICK LINKS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ARTICLE STATISTICS |
Submission to First Decision |
35 Days |
Acceptance Rate |
26% |
Acceptance to Publication |
28 Days |
*Average article statistics from the last 12 months data |
COVID-19 RESEARCH |
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and health care providers, the post COVID-19 condition (or long COVID) includes long term symptoms which may persist for months or years after SARS-CoV-2 infection. We will consider submissions related to all aspects of COVID-19 and Long COVID, and process the manuscripts in priority. |